Assessment of the third-trimester fetus using 3-dimensional volumes: A pilot study

2007 ◽  
Vol 35 (5) ◽  
pp. 231-237 ◽  
Author(s):  
Bryann Bromley ◽  
Thomas D. Shipp ◽  
Beryl Benacerraf,
Keyword(s):  
Pilot Study ◽  
Third Trimester ◽  
3 Dimensional ◽  
The Third

scholarly journals G261(P) Energy expenditure in the third trimester in rural pregnant women in jumla nepal: a pilot study using the actiheart accelerometer

2015 ◽  
Vol 100 (Suppl 3) ◽  
pp. A114.2-A115
Author(s):  
H Costello ◽  
J Talbot-Ponsonby ◽  
S Dulal ◽  
B Bhandari ◽  
D Adikari ◽  
...  
Keyword(s):  
Pilot Study ◽  
Energy Expenditure ◽  
Pregnant Women ◽  
Third Trimester ◽  
The Third

Effects of Mindful Yoga on Sleep in Pregnant Women: A Pilot Study

2010 ◽  
Vol 11 (4) ◽  
pp. 363-370 ◽  
Author(s):  
Amy E. Beddoe ◽  
Kathryn A. Lee ◽  
Sandra J. Weiss ◽  
Holly Powell Kennedy ◽  
Chin-Po Paul Yang
Keyword(s):  
Pilot Study ◽  
Sleep Disturbance ◽  
Pregnant Women ◽  
Sample Size ◽  
Small Sample ◽  
Second Trimester ◽  
Third Trimester ◽  
The Third ◽  
Nulliparous Women ◽  
Wrist Actigraphy

Purpose: The purpose of this experimental pilot study was to measure the effects of a mindfulness-based yoga intervention on sleep in pregnant women. Methods: Fifteen healthy, nulliparous women in their second or third trimesters with singleton pregnancies attended weekly mindfulness meditation and prenatal Hatha yoga classes in the community for 7 weeks. Sleep variables, as estimated by 72 hr of continuous wrist actigraphy and the General Sleep Disturbance Scale (GSDS), were recorded at baseline (Time 1) and postintervention (Time 2). Control data were obtained by evaluating sleep in the third-trimester group at Time 1. Due to small sample size, data were analyzed using parametric and nonparametric statistics. Results: Women who began the intervention in the second trimester had significantly fewer awakenings, less wake time during the night, and less perceived sleep disturbance at Time 2 than at baseline. Those who began during the third trimester had poorer sleep over time in spite of the intervention. Women who began the intervention in their second trimester had less awake time at Time 2 compared to third-trimester controls at Time 1. Conclusions: Mindful yoga shows promise for women in their second trimester of pregnancy to diminish total number of awakenings at night and improve sleep efficiency and merits further exploration. Results from this pilot study provide the data to estimate sample size and design and implement powered and more controlled studies in the future.

scholarly journals P16.02: The learning curve of medical students for ultrasound in the third trimester of pregnancy: a pilot study

2019 ◽  
Vol 54 (S1) ◽  
pp. 206-206
Author(s):  
R. Sima ◽  
A.D. Stanescu ◽  
M.A. Moga ◽  
G. Olaru ◽  
P. Liana
Keyword(s):  
Medical Students ◽  
Pilot Study ◽  
Learning Curve ◽  
Third Trimester ◽  
The Third

Direct prediction of amniotic fluid volume in the third trimester by 3-dimensional measurements of intrauterine pockets: A tool for routine clinical use

2002 ◽  
Vol 186 (2) ◽  
pp. 245-250
Author(s):  
Yoshiyasu Hombo ◽  
Michio Ohshita ◽  
Shosuke Takamura ◽  
Kiyoshi Uchide ◽  
Masaki Inoue
Keyword(s):  
Amniotic Fluid ◽  
Fluid Volume ◽  
Clinical Use ◽  
Third Trimester ◽  
3 Dimensional ◽  
The Third ◽  
Amniotic Fluid Volume ◽  
Dimensional Measurements

Assessment of anxiety disorders and related factors at the third trimester of pregnancy

2009 ◽  
Vol 13 (3) ◽  
pp. 132-136 ◽  
Author(s):  
İmran Tekgöz
Keyword(s):  
Anxiety Disorders ◽  
Third Trimester ◽  
Related Factors ◽  
The Third

Correlations Between the Values of Maternal Glycemia from the Last Trimester of Pregnancy and Fetal Birth Weight

2013 ◽  
Vol 20 (3) ◽  
pp. 259-265
Author(s):  
Monica Vereş ◽  
Aurel Babeş ◽  
Szidonia Lacziko
Keyword(s):  
First Trimester ◽  
Mean Value ◽  
Fetal Macrosomia ◽  
Entire Group ◽  
Third Trimester ◽  
The Third ◽  
Group I ◽  
Fetal Birth Weight ◽  
First Trimester Of Pregnancy ◽  
The Mean

Abstract Background and aims: Gestational diabetes represents a form of diabetes diagnosed during pregnancy that is not clearly overt diabetes. In the last trimester of gestation the growth of fetoplacental unit takes place, thus maternal hyperglycemia will determine an increased transplacental passage, hyperinsulinemia and fetal macrosomia. The aim of our study was that o analyzing the effect of maternal glycemia from the last trimester of pregnancy over fetal weight. Material and method: We run an observational study on a group of 46 pregnant women taken into evidence from the first trimester of pregnancy, separated in two groups according to blood glucose determined in the third trimester (before birth): group I normoglycemic and group II with hyperglycemia (>92mg/dl). Results: The mean value of third trimester glycemia for the entire group was of 87.13±22.03. The mean value of the glycemia determined in the third trimester of pregnancy was higher in the second group (109.17 mg/dl) in comparison to the first group (74.,21 mg/dl). The ROC curve for third trimester glycemia as fetal macrosomia appreciation test has an AUC of 0.517. Conclusions: Glycemia determined in the last trimester of pregnancy cannot be used alone as the predictive factor for fetal macrosomia.

Features of the course and treatment of glaucoma during pregnancy

2020 ◽  
Vol 98 (3) ◽  
pp. 178-184
Author(s):  
T. V. Chernyakova ◽  
A. Yu. Brezhnev ◽  
I. R. Gazizova ◽  
A. V. Kuroyedov ◽  
A. V. Seleznev
Keyword(s):  
Pregnant Women ◽  
Laser Treatment ◽  
Progressive Disease ◽  
Clinical Course ◽  
The Other ◽  
Third Trimester ◽  
The Third ◽  
Chronic Progressive Disease ◽  
Hypotensive Therapy ◽  
Eye Pressure

In the review we have integrated all up-to-date knowledge concerning clinical course and treatment of glaucoma among pregnant women to help specialists choose a proper policy of treatment for such a complicated group of patients. Glaucoma is a chronic progressive disease. It rarely occurs among childbearing aged women. Nevertheless the probability to manage pregnant patients having glaucoma has been recently increasing. The situation is complicated by the fact that there are no recommendations on how to treat glaucoma among pregnant women. As we know, eye pressure is progressively going down from the first to the third trimester, so we often have to correct hypotensive therapy. Besides, it is necessary to take into account the effect of applied medicines on mother health and evaluate possible teratogenic complications for a fetus. The only medicine against glaucoma which belongs to category B according to FDA classification is brimonidine. Medicines of the other groups should be prescribed with care. Laser treatment or surgery may also be a relevant decision when monitoring patients who are planning pregnancy or just bearing a child. Such treatment should be also accompanied by medicines.

Sign in / Sign up

Export Citation Format

Share Document